Iterum Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $390 | $0 | $0 | $0 |
Gross Profit | 370 | -696 | -342 | -239 |
EBITDA | -8,051 | -5,650 | -3,948 | -5,422 |
EBIT | -8,406 | -6,001 | -4,297 | -5,683 |
Net Income | -8,979 | -6,509 | -4,891 | -6,582 |
Net Change In Cash | 390 | 0 | 0 | 0 |
Free Cash Flow | -7,860 | -4,751 | -3,062 | -4,256 |
Cash | 11,002 | 13,026 | 12,652 | 24,125 |
Basic Shares | 45,801 | 39,935 | 34,060 | 19,699 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -254 | -1,750 | -1,800 | -2,104 |
EBITDA | -21,728 | -34,580 | -39,972 | -83,202 |
EBIT | -22,012 | -36,330 | -41,772 | -85,306 |
Net Income | -24,774 | -38,371 | -44,434 | -91,564 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,772 | -39,343 | -18,535 | -15,903 |
Cash | 24,125 | 6,071 | 21,092 | 27,446 |
Basic Shares | 19,699 | 12,962 | 12,237 | 10,891 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.20 |
2025-06-30 | -$0.16 |
2025-03-31 | -$0.14 |
